Prognostic Significance of Fatty Liver Disease in Bariatric Patients
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
Prospective non-randomized intervention case control study on patients with a BMI \> 35. The intervention group/cases (n=600) is comprised of bariatric patients who undergo bariatric surgery and the control group (n=600) of age, weight and comorbidity matched patients who choose not to undergo bariatric surgery. The overall aim is to examine prevalence of the spectrum of fatty liver disease (NAFLD) in these patients and the prognostic significance of NAFLD.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age \> 18 years
• BMI \>35 kg/m2 and referred for bariatric surgery at Hospital of South West Jutland, Denmark
• Able to give written informed consent.
• Age \> 18 years
• BMI \>35 kg/m2 with no wish to undergo bariatric surgery.
• Able to give written informed consent.
Locations
Other Locations
Denmark
Hospital of Southwest Jutland
RECRUITING
Esbjerg
Contact Information
Primary
Mette M Lauridsen, MD PhD
mette.enok.munk.lauridsen@rsyd.dk
4579182000
Time Frame
Start Date: 2018-08-15
Estimated Completion Date: 2038-04-01
Participants
Target number of participants: 1200
Treatments
Experimental: Intervention
The intervention is bariatric surgery (Roux en Y gastric bypass or gastric sleeve operation).
No_intervention: Control
Age, BMI and co-morbidity matched group who do not undergo surgery.
Related Therapeutic Areas
Sponsors
Collaborators: University of Southern Denmark, Odense University Hospital, Esbjerg University Hospital of South-West Jutland
Leads: Esbjerg Hospital - University Hospital of Southern Denmark